Projects

doc. MUDr. Jozef Török, CSc.

National

Current
  • Cardiovascular protection mediated by alpha 1 AMPK against metabolic syndrome-mediated endothelial dysfunction - identifying new risk factors
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Hyperuricemia in various comorbidities of the metabolic syndrome - mechanisms of the effect of uric acid on endothelial function and erythrocyte deformability.
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
Finished
  • Mesenteric perivascular fat and its specific role in regulation of intestinal circulation in rats with different feeding regimens
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2023
  • New perspectives in the treatment of cardiovascular complications associated with COVID-19
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
  • Relationship between body adiposity and functional properties of arteries in rat
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • Cardiovascular Effects of Nanoencapsulated Simvastain and Coenzyme Q10 in Experimental Hyperlipidemia (KANASTA)
    Program: Other projects
    Duration: 27. 11. 2015 – 26. 11. 2018
  • The role of perivascular adipose tissue in the regulation of vascular tone in rats with cardiovascular dysfunction
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2017
  • Effect of aging on the endothelial function in experimental hypertension
    Program: Other projects
    Duration: 17. 4. 2014 – 17. 4. 2017
  • -
    Program: Other projects
    Duration: 19. 7. 2013 – 31. 12. 2015
  • Characterization of cardiovascular and metabolic changes in fructose-induced metabolic syndrome in the rat
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2014
  • Effect of antioxidants on blood pressure and manifestation of sympathetic activity in conduit arteries in rats with experimental hypertension
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Hypertension and diabetes as the parts of metabolic syndrome: the effects of antioxidant therapy
    Program: SRDA
    Duration: 1. 6. 2008 – 31. 12. 2010
  • Long-term administration of low dose of L-NAME: Possibility to improve function of vessel wall in border hypertension?
    Program: VEGA
    Duration: 1. 1. 2007 – 31. 12. 2009
  • Mechanism of indapamide effect on the prevention and treatment of experimental hypertension and organ damage
    Program: VEGA
    Duration: 1. 1. 2006 – 1. 12. 2008
  • Investigation of preventive effect of vasoactive substances on development of structure and function of cardiovascular system in SHR as an experimental model of humen essential hypertension
    Program: VEGA
    Duration: 1. 1. 2006 – 1. 12. 2008
  • Pharmacological treatment of hypertension in early stage of its development
    Program: VEGA
    Duration: 1. 1. 2006 – 1. 12. 2008
  • Role of bioflavonoids in prevention of social stress-induced hypertension
    Program: SRDA
    Duration: 1. 1. 2005 – 31. 12. 2007
  • The interaction of stress and genetic factors in the etiology of high blood pressure and behavioral failure: the role of nitric oxide
    Program: VEGA
    Duration: 1. 1. 2004 – 31. 12. 2006
Employees